Veraxa Biotech Holding AG (VRXA)

–

USD

–(–)

Open

$2.11

Prev. Close

$1.86

High

$2.30

Low

$2.08

Company Profile

Veraxa Biotech Holding AG is a clinical-stage biopharmaceutical company, formed via a merger with Voyager Acquisition Corp., focusing on developing next-generation cancer therapies such as antibody-drug conjugates (ADCs) and bispecific T-cell engagers. [64, 65]

CEOChristoph Antz

SectorHealthcare

Recently from Cashu

Industry

Biotechnology

Employees8

IPO DateJun 9, 2026

ExchangeNASDAQ

Exchange NameNASDAQ

CurrencyUSD

Headquarters & Contact

AddressIm Neuenheimer Feld 584

City / State / ZIPHeidelberg, ZH, 69120

CountryGermany

Phone49 6221 3521330

Websitehttps://www.veraxa.com